In a new video podcast, Principal Investigator Etta Pisano, MD, FACR, explains how taking part in the Tomosynthesis Mammographic Imaging Screening Trial (TMIST) benefits your practice and your patients.
On July 24, Dr. Pisano will show AHRA 2019 attendees how TMIST participation enables your practice to shape breast cancer screening, provide covered screening to uninsured women and strengthen your bottom line.
TMIST participation is a good opportunity for you to do something good for your practice, your patients and for radiology.
Seventy sites throughout North America are already taking part. The number of women participating in the trial has doubled in recent months.
The trial would like to add 70 more sites and tens of thousands more women. Now is the time to join TMIST!
Visit acr.org/TMIST to find out how and why your practice should take part in the largest randomized controlled breast cancer screening trial in decades.
Email TMIST@acr.org with any questions you may have about TMIST.